| 000 | 00999 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513231435.0 | ||
| 264 | 0 | _c20010315 | |
| 008 | 200103s 0 0 eng d | ||
| 022 | _a0277-0008 | ||
| 024 | 7 |
_a10.1592/phco.21.1.35.34440 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFish, D N | |
| 245 | 0 | 0 |
_aGatifloxacin, an advanced 8-methoxy fluoroquinolone. _h[electronic resource] |
| 260 |
_bPharmacotherapy _cJan 2001 |
||
| 300 |
_a35-59 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBacteria _xdrug effects |
| 650 | 0 | 4 |
_aBacterial Infections _xdrug therapy |
| 650 | 0 | 4 | _aFluoroquinolones |
| 650 | 0 | 4 | _aGatifloxacin |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPharmacokinetics |
| 700 | 1 | _aNorth, D S | |
| 773 | 0 |
_tPharmacotherapy _gvol. 21 _gno. 1 _gp. 35-59 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1592/phco.21.1.35.34440 _zAvailable from publisher's website |
| 999 |
_c11129930 _d11129930 |
||